<p>CBP just announced that now all FDA-regulated products must be submitted with appropriate data sets regardless of de minimis value. With increased global reciprocal tariffs potentially around the corner, could this signal a broader de minimis prohibition?</p>

CBP just announced that now all FDA-regulated products must be submitted with appropriate data sets regardless of de minimis value. With increased global reciprocal tariffs potentially around the corner, could this signal a broader de minimis prohibition?

Two Minutes in Trade - Is the End of De Minimis Near?

Staying on top of the international trade developments in Washington can be difficult, but listening to Two Minutes in Trade is like having your own daily briefing. The podcast covers topics including the Section 301 tariffs on China, free trade agreements like the USMCA, and legislative responses to trade issues. TMIT features customs attorneys and trade consultants from the international trade law firm of Sandler, Travis and Rosenberg, P.A. Learn more at www.strtrade.com.

Share Two Minutes in Trade - Is the End of De Minimis Near?

Sign up to save your podcasts

Two Minutes in Trade - Is the End of De Minimis Near?

Two Minutes in Trade - Is the End of De Minimis Near?

More shows like Two Minutes in Trade

Economist Podcasts

WSJ Opinion: Potomac Watch

WSJ Your Money Briefing

WSJ What’s News

Bloomberg Businessweek

ChinaPower

The President’s Inbox

WSJ Minute Briefing

Bold Names

The Trade Guys

The Asia Chessboard

POLITICO Tech

The Big Take

The Peter Zeihan Podcast Series

Simply Trade